Demant A/S (CPH:DEMANT)
Denmark · Delayed Price · Currency is DKK 191.80
+2.30 (1.21%)
Apr 8, 2026, 4:59 PM CET
Demant Market Cap
Demant has a market cap or net worth of 40.45 billion as of April 8, 2026. Its market cap has decreased by -24.94% in one year.
Market Cap
40.45B
Enterprise Value
60.19B
Revenue
22.97B
Ranking
n/a
PE Ratio
17.13
Stock Price
191.80
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 40.45B, an increase of 1,808.99%. That is a compound annual growth rate of 10.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 40.45B | -11.76% |
| Dec 30, 2025 | 45.84B | -20.30% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.05T |
| Genmab | 107.96B |
| Coloplast | 99.70B |
| ALK-Abelló | 45.60B |
| H. Lundbeck | 39.07B |
| Zealand Pharma | 21.04B |
| Ambu A/S | 18.31B |
| Bavarian Nordic | 15.11B |